Skip to main content

Sancuso FDA Approval History

FDA Approved: Yes (First approved September 12, 2008)
Brand name: Sancuso
Generic name: granisetron
Dosage form: Transdermal Patch
Company: ProStrakan Group plc
Treatment for: Nausea/Vomiting, Chemotherapy Induced

Sancuso (granisetron transdermal system) is an anti-emetic transdermal delivery system indicated for the control of nausea and vomiting in patients receiving moderately and/or highly nausea-inducing chemotherapy.

Development timeline for Sancuso

Sep 15, 2008Approval FDA Approves Sancuso, the First and Only Patch for Preventing Nausea and Vomiting in Cancer Patients Undergoing Chemotherapy
Jun  2, 2008ProStrakan Presents Update on Sancuso US Regulatory Review Status

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.